Institutional investors control 15.97% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended December 2017, these large investors purchased a net $12.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRIMECAP MANAGEMENT CO. Bought 5.6 Million shares of AstraZeneca PLC
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.6 Million shares of AstraZeneca PLC
CAPITAL RESEARCH & MANAGEMENT CO... Bought 2.5 Million shares of AstraZeneca PLC